The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Multiple, diverse senile plaque–associated proteins are ligands of an apolipoprotein e receptor, the α2‐macroglobulin receptor/low‐density‐lipoprotein receptor—related protein
Abstract
Both apolipoprotein E and its receptor, the low‐density‐lipoprotein receptor‐related protein (LRP), are associated with senile plaques in Alzheimer's disease. We examined the relationship of other LRP‐related molecules to senile plaques. LRP is a multifunctional receptor that blinds and rapidly internalizes at least seven ligands: apolipoprotein E, activated α 2‐macroglobulin, tissue and urokinase‐type plasminogen activators, plasminogen activator inhibitor‐1, lipoprotein lipase, and lactoferrin. Using immunohistochemistry, we showed that all of these ligands, representing a diverse group of otherwise apparently unrelated proteins, accumulate on senile plaques. We also studied expression of the receptor‐associated protein, a physiological inhibitor of LRP, in the hippocampal formation from normal subjects and Alzheimer's disease patients. Receptor‐associated protein colocalizes with LRP on neuronal soma, but not on neuronal processes or reactive astrocytes. It is not present on senile plaques. These results suggest that senile plaque‐associated LRP can bind its ligands, but clearance of these compounds may be impaired in the vicinity of senile plaques.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In senile plaques, LRP1 ligands co-deposit with Aβ, indicating a loss of LRP1 function in AD.
“In senile plaques, LRP1 ligands, like apoE, urokinase-type plasminogen activator, tissue plasminogen activator, and lactoferrin, co-deposit with Aβ, all together indicating a loss of LRP1 function in AD (14).”
From Endothelial LRP1 transports amyloid-β1–42 across the blood-brain barrier (2015) · cites this paper as [14]
Immunoreactivity for LRP and ligands including apoE and α2-macroglobulin is found associated with senile plaques.
“Fourth, immunoreactivity for LRP and a number of its ligands including apoE and ␣ 2 -macroglobulin is found associated with senile plaques (30).”
From Apolipoprotein E Receptors Mediate the Effects of β-Amyloid on Astrocyte Cultures (2000) · cites this paper as [30]
Activated astrocytes used in the experiments express both LDLR and LRP by immunostaining.
“By immunostaining, these activated astrocytes express both the LDLR and LRP (data not shown), consistent with the previous observations summarized above that these are the two primary members of the LDLR family that are expressed by activated astrocytes (4 -7, 29 -31).”
From Apolipoprotein E Receptors Mediate the Effects of β-Amyloid on Astrocyte Cultures (2000) · cites this paper as [30]
Citations
Cites
The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor
Kang, J., Lemaire, H.-G., Unterbeck, A., Salbaum, J. M., Masters, C. L., Grzeschik, K.-H., Multhaup, G., Beyreuther, K., & Müller-Hill, B. (1987) · Nature · doi:10.1038/325733a0 · Cited by 4,619
Amyloid β-peptide is produced by cultured cells during normal metabolism
Haass, C., Schlossmacher, M. G., Hung, A. Y., Vigo-Pelfrey, C., Mellon, A., Ostaszewski, B. L., Lieberburg, I., Koo, E. H., Schenk, D., Teplow, D. B., et al. (1992) · Nature · doi:10.1038/359322a0 · Cited by 1,921
Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease
Corder, E. H., Saunders, A. M., Risch, N. J., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Rimmler, J. B., Locke, P. A., Conneally, P. M., Schmader, K. E., et al. (1994) · Nature Genetics · doi:10.1038/ng0694-180 · Cited by 1,920
Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids
Seubert, P., Vigo-Pelfrey, C., Esch, F., Lee, M., Dovey, H., Davis, D., Sinha, S., Schiossmacher, M., Whaley, J., Swindlehurst, C., et al. (1992) · Nature · doi:10.1038/359325a0 · Cited by 1,731
Amyloid β Protein Gene: cDNA, mRNA Distribution, and Genetic Linkage Near the Alzheimer Locus
Tanzi, R. E., Gusella, J. F., Watkins, P. C., Bruns, G. A. P., St George-Hyslop, P., Van Keuren, M. L., Patterson, D., Pagan, S., Kurnit, D. M., & Neve, R. L. (1987) · Science · doi:10.1126/science.2949367 · Cited by 1,611
Production of the Alzheimer Amyloid β Protein by Normal Proteolytic Processing
Shoji, M., Golde, T. E., Ghiso, J., Cheung, T. T., Estus, S., Shaffer, L. M., Cai, X.-D., McKay, D. M., Tintner, R., Frangione, B., et al. (1992) · Science · doi:10.1126/science.1439760 · Cited by 1,447
Astrocytes synthesize apolipoprotein E and metabolize apolipoprotein E-containing lipoproteins
Pitas, R. E., Boyles, J. K., Lee, S. H., Foss, D., & Mahley, R. W. (1987) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(87)90295-5 · Cited by 693
Immunoglobulins and complement factors in senile plaques: An immunoperoxidase study
Eikelenboom, P., & Stam, F. C. (1982) · Acta Neuropathologica · doi:10.1007/bf00685397 · Cited by 454
Flagged first, then by citations
Research works printed but not linked: 44
- 10.1016/S0006-291X(84)80190-4 · DOI · Paper page
- 10.1126/science.3810169 · DOI
- 10.1073/pnas.84.19.6953 · DOI
- 10.1016/0022-2836(91)90881-6 · DOI
- 10.1073/pnas.90.5.2092 · DOI · Paper page
- 10.1111/j.1750-3639.1991.tb00666.x · DOI
- 10.1006/bbrc.1993.1663 · DOI
- 10.1016/0014-5793(91)80737-N · DOI · Paper page
- 10.1016/0197-4580(93)90006-W · DOI
- 10.1016/0092-8674(88)90462-X · DOI
- 10.1016/0006-8993(91)91092-F · DOI · Paper page
- 10.1016/0304-3940(92)90444-C · DOI · Paper page
- 10.1016/0896-6273(93)90070-8 · DOI · Paper page
- 10.1073/pnas.90.20.9649 · DOI · Paper page
- Kawamata T., 1993, Lactotransferrin immunocytochemistry in Alzheimer and normal human brain, Am J Pathol, 142, 1574
- Snow AD, 1988, The presence of heparan sulfate proteoglycans in the neuritic plaques and congophilic angiopathy in Alzheimer's disease, Am J Pathol, 133, 456
- 10.1073/pnas.90.5.1977 · DOI · Paper page
- 10.1212/WNL.43.8.1467 · DOI · Paper page
- 10.1016/0140-6736(93)91705-Q · DOI · Paper page
- 10.1016/0304-3940(94)91074-X · DOI · Paper page
- 10.1126/science.3283935 · DOI · Paper page
- Strittmatter WJ, 1993, Binding of human apolipoprotein E to synthetic amyloid β peptide: isoform‐specific effects and implications for late‐onset Alzheimer disease, Proc Natl Acad Sci USA, 90, 8098, 10.1073/pnas.90.17.8098 · DOI · Paper page
- 10.1016/S0021-9258(18)47945-8 · DOI · Paper page
- 10.1073/pnas.85.24.9821 · DOI
- Wolf BB, 1992, Characterization and immunohistochemical localization of α2‐macroglobulin receptor (low‐density lipoprotein receptor‐related protein) in human brain, Am J Pathol, 141, 37
- 10.1007/BF00353892 · DOI
- 10.1007/BF03160029 · DOI
- 10.1002/j.1460-2075.1988.tb03306.x · DOI
- 10.1002/j.1460-2075.1990.tb08301.x · DOI
- 10.1073/pnas.86.15.5810 · DOI
- Strickland DK, 1990, Sequence identity between the α2‐macroglobulin receptor and low density lipoprotein receptor‐related protein suggests that this molecule is a multifunctional receptor, J Biol Chem, 265, 17401, 10.1016/S0021-9258(18)38172-9 · DOI · Paper page
- Moestrup SK, 1991, Analysis of ligand recognition by the purified α2‐macroglobulin receptor (low density lipoprotein receptor‐related protein), J Biol Chem, 266, 14011, 10.1016/S0021-9258(18)92803-6 · DOI
- 10.1016/S0021-9258(18)35732-6 · DOI
- 10.1038/341162a0 · DOI
- 10.1073/pnas.89.16.7427 · DOI
- Kounnas MZ, 1993, Low density lipoprotein receptor‐related protein/α2‐macroglobulin receptor mediates cellular uptake of pro‐urokinase, J Biol Chem, 268, 21862, 10.1016/S0021-9258(20)80620-6 · DOI
- Nykjaer A., 1992, Purified α2‐macroglobulin receptor/LDL receptor‐related protein bind urokinase‐plasminogen activator inhibitor type‐1 complex, J Biol Chem, 267, 14543, 10.1016/S0021-9258(18)42072-8 · DOI
- 10.1073/pnas.89.16.7422 · DOI
- 10.1016/S0021-9258(19)50384-2 · DOI · Paper page
- 10.1016/S0021-9258(18)54845-6 · DOI · Paper page
- Osmand AP, 1991, Alzheimer's disease: basic mechanisms, diagnosis and therapeutic strategies, 219
- 10.1097/00005072-199201000-00009 · DOI
- 10.1016/S0021-9258(19)36811-5 · DOI · Paper page
- 10.1016/0166-2236(88)90182-8 · DOI
Cited by
Sorted by citations
Inflammation and Alzheimer’s disease
Akiyama, H. (2000) · Neurobiology of Aging · doi:10.1016/s0197-4580(00)00124-x · Cited by 4,514
MCGEER, P., & MCGEER, E. (1995) · Brain Research Reviews · doi:10.1016/0165-0173(95)00011-9 · Cited by 1,287
Apolipoprotein E and Apolipoprotein E Receptors: Normal Biology and Roles in Alzheimer Disease
Holtzman, D. M., Herz, J., & Bu, G. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006312 · Cited by 782
Bales, K. R., Verina, T., Cummins, D. J., Du, Y., Dodel, R. C., Saura, J., Fishman, C. E., DeLong, C. A., Piccardo, P., Petegnief, V., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.15233 · Cited by 486
Endothelial LRP1 transports amyloid-β1–42 across the blood-brain barrier
Storck, S. E., Meister, S., Nahrath, J., Meißner, J. N., Schubert, N., Di Spiezio, A., Baches, S., Vandenbroucke, R. E., Bouter, Y., Prikulis, I., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci81108 · Cited by 477
Redox‐Active Metals, Oxidative Stress, and Alzheimer's Disease Pathology
HUANG, X., MOIR, R. D., TANZI, R. E., BUSH, A. I., & ROGERS, J. T. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1306.012 · Cited by 425
Kang, D. E., Pietrzik, C. U., Baum, L., Chevallier, N., Merriam, D. E., Kounnas, M. Z., Wagner, S. L., Troncoso, J. C., Kawas, C. H., Katzman, R., et al. (2000) · Journal of Clinical Investigation · doi:10.1172/jci11013 · Cited by 354
Liang, W. S., Dunckley, T., Beach, T. G., Grover, A., Mastroeni, D., Ramsey, K., Caselli, R. J., Kukull, W. A., McKeel, D., Morris, J. C., et al. (2008) · Physiological Genomics · doi:10.1152/physiolgenomics.00242.2007 · Cited by 309
Shinohara, M., Tachibana, M., Kanekiyo, T., & Bu, G. (2017) · Journal of Lipid Research · doi:10.1194/jlr.r075796 · Cited by 297
Kanekiyo, T., & Bu, G. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00093 · Cited by 281
Zlokovic, B. V., Deane, R., Sagare, A. P., Bell, R. D., & Winkler, E. A. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.07002.x · Cited by 261
Neurovascular Dysfunction and Faulty Amyloid -Peptide Clearance in Alzheimer Disease
Sagare, A. P., Bell, R. D., & Zlokovic, B. V. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a011452 · Cited by 251
Huynh, T.-P. V., Davis, A. A., Ulrich, J. D., & Holtzman, D. M. (2017) · Journal of Lipid Research · doi:10.1194/jlr.r075481 · Cited by 210
Molecular Genetics of Late‐Onset Alzheimer's Disease
Kamboh, M. I. (2004) · Annals of Human Genetics · doi:10.1046/j.1529-8817.2004.00110.x · Cited by 170
Insulin metabolism in Alzheimer’s disease differs according to apolipoprotein E genotype and gender
Craft, S., Asthana, S., Schellenberg, G., Cherrier, M., Baker, L. D., Newcomer, J., Plymate, S., Latendresse, S., Petrova, A., Raskind, M., et al. (1999) · Neuroendocrinology · doi:10.1159/000054469 · Cited by 154
Martel, C. L., Mackic, J. B., Matsubara, E., Governale, S., Miguel, C., Miao, W., McComb, J. G., Frangione, B., Ghiso, J., & Zlokovic, B. V. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69051995.x · Cited by 149
Thal, D. R., Schultz, C., Dehghani, F., Yamaguchi, H., Braak, H., & Braak, E. (2000) · Acta Neuropathologica · doi:10.1007/s004010000242 · Cited by 136
Gene expression profiling of scrapie-infected brain tissue
Riemer, C., Neidhold, S., Burwinkel, M., Schwarz, A., Schultz, J., Krätzschmar, J., Mönning, U., & Baier, M. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.08.124 · Cited by 108
Lipoprotein Lipase in the Brain and Nervous System
Wang, H., & Eckel, R. H. (2012) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-071811-150703 · Cited by 105
Apolipoprotein E Receptors Mediate the Effects of β-Amyloid on Astrocyte Cultures
LaDu, M. J., Shah, J. A., Reardon, C. A., Getz, G. S., Bu, G., Hu, J., Guo, L., & Van Eldik, L. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000602200 · Cited by 103
EFAD transgenic mice as a human APOE relevant preclinical model of Alzheimerʼns disease
Tai, L. M., Balu, D., Avila-Munoz, E., Abdullah, L., Thomas, R., Collins, N., Valencia-Olvera, A. C., & LaDu, M. J. (2017) · Journal of Lipid Research · doi:10.1194/jlr.r076315 · Cited by 93
Van Uden, E., Mallory, M., Veinbergs, I., Alford, M., Rockenstein, E., & Masliah, E. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-21-09298.2002 · Cited by 91
Frautschy, S. A., Horn, D. L., Sigel, J. J., Harris-White, M. E., Mendoza, J. J., Yang, F., Saido, T. C., & Cole, G. M. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-20-08311.1998 · Cited by 65
Hirsch-Reinshagen, V., & Wellington, C. L. (2007) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e32813aeabf · Cited by 61
Mulder, M., & Terwel, D. (1998) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000022429 · Cited by 40
Novel Combinatorial Therapeutic Targeting of PAI-1(SERPINE1) Gene Expression in Alzheimer’s Disease
M. Kutz, S., E. Higgins, C., & J. Higgins, P. (2012) · Molecular Medicine & Therapeutics · doi:10.4172/2324-8769.1000106 · Cited by 36
Studies on the first described Alzheimer's disease amyloid β mutant, the Dutch variant
Levy, E., Prelli, F., & Frangione, B. (2006) · Journal of Alzheimer's Disease · doi:10.3233/jad-2006-9s337 · Cited by 24
Metadata
- Authors
- Rebeck, G. W., Harr, S. D., Hyman, B. T., & Strickland, D. K.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1995-02
- Volume
- 37
- Issue
- 2
- Pages
- 211-217
- ISSN
- 0364-5134
- 1531-8249
- Cited by
- 232
- References
- 8
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review